Javascript must be enabled to continue!
The hsa_circ_0024183 may affects glioblastoma progression by interacting with the protooncogene SALL4
View through CrossRef
Abstract
Purpose: The pathogenesis of glioma is not clear, SALL4 is a protooncogene and has been shown to promote the growth of glioma cells. CircRNAs have been shown to play a role in the development of tumors, but the relationship between SALL4 and circRNAs has not been well characterized. The aim of this study is to establish the association between SALL4 and circRNAs.Methods: The circRNAs and miRNAs related to SALL4 screened before were detected in glioma and normal brain tissue samples, then hsa_circ_0024183 was selected to determine its effect on glioma progression in vivo and vitro. The interaction between hsa_circ_0024183, miR-485-5p and SALL4 was clarified by double luciferase assay and RNA immunoprecipitation analysis.Results: The expression of hsa_circ_0024183 was significantly higher in glioma patients and human glioblastoma cell lines than in normal brain(P<0.05). GBM patients with higher hsa_circ_0024183 expression had worse outcome. The reduction of hsa_circ_0024183 by siRNA was found to decrease the proliferation, migration, and invasion abilities of GBM cells and block their cell cycles at the S phase. Furthermore, a decrease of hsa_circ_0024183 expression in GBM cells was found to inhibit their tumorigenicity in nude mice. Mechanistic studies revealed that hsa_circ_0024183 can regulate SALL4 expression by sponging miR-485-5p. And hsa_circ_0024183 RNA could directly bind to SALL4 protein.Conclusion: Interference with hsa_circ_0024183 can reduce the expression of SALL4 and the binding of hsa_circ_0024183 to SALL4 protein. It may affect the progression of glioma through the PTEN/PI3K/Akt pathway. This discovery provides an opportunity to develop potential targeted therapy against glioma.
Research Square Platform LLC
Title: The hsa_circ_0024183 may affects glioblastoma progression by interacting with the protooncogene SALL4
Description:
Abstract
Purpose: The pathogenesis of glioma is not clear, SALL4 is a protooncogene and has been shown to promote the growth of glioma cells.
CircRNAs have been shown to play a role in the development of tumors, but the relationship between SALL4 and circRNAs has not been well characterized.
The aim of this study is to establish the association between SALL4 and circRNAs.
Methods: The circRNAs and miRNAs related to SALL4 screened before were detected in glioma and normal brain tissue samples, then hsa_circ_0024183 was selected to determine its effect on glioma progression in vivo and vitro.
The interaction between hsa_circ_0024183, miR-485-5p and SALL4 was clarified by double luciferase assay and RNA immunoprecipitation analysis.
Results: The expression of hsa_circ_0024183 was significantly higher in glioma patients and human glioblastoma cell lines than in normal brain(P<0.
05).
GBM patients with higher hsa_circ_0024183 expression had worse outcome.
The reduction of hsa_circ_0024183 by siRNA was found to decrease the proliferation, migration, and invasion abilities of GBM cells and block their cell cycles at the S phase.
Furthermore, a decrease of hsa_circ_0024183 expression in GBM cells was found to inhibit their tumorigenicity in nude mice.
Mechanistic studies revealed that hsa_circ_0024183 can regulate SALL4 expression by sponging miR-485-5p.
And hsa_circ_0024183 RNA could directly bind to SALL4 protein.
Conclusion: Interference with hsa_circ_0024183 can reduce the expression of SALL4 and the binding of hsa_circ_0024183 to SALL4 protein.
It may affect the progression of glioma through the PTEN/PI3K/Akt pathway.
This discovery provides an opportunity to develop potential targeted therapy against glioma.
Related Results
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
Abstract
Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a ...
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract
Background: The standard therapy for glioblastoma patients is tumor resection followed by radiotherapy and temozolomide chemotherapy. Although glioblastoma ...
P10.36.B ROLE OF AMPK IN GLIOBLASTOMA BIOENERGETICS
P10.36.B ROLE OF AMPK IN GLIOBLASTOMA BIOENERGETICS
Abstract
BACKGROUND
Glioblastoma is the most prevalent and aggressive primary brain tumor. AMP-activated kinase (AMPK), the main...
Abstract 2205: Exploring the presence and role of causative viruses in glioblastoma using a multi-omics approach
Abstract 2205: Exploring the presence and role of causative viruses in glioblastoma using a multi-omics approach
Abstract
Glioblastoma (GB) is the most aggressive brain cancer with a poor survival rate. While molecular markers have been established to improve treatment response...
Correlation between SALL4 stemness marker and bone morphogenetic protein signaling genes in esophageal squamous cell carcinoma
Correlation between SALL4 stemness marker and bone morphogenetic protein signaling genes in esophageal squamous cell carcinoma
AbstractSALL4, as a stemness marker, plays a key role in the maintenance of pluripotency and selfârenewal of cancer stem cells. To elucidate probable linkage between SALL4 stemness...
Clinical Insights and Management Strategies for Gliosarcoma: A Case Report
Clinical Insights and Management Strategies for Gliosarcoma: A Case Report
Abstract
Introduction: Gliosarcoma (GSM) is a rare, aggressive primary CNS tumor and a histopathological variant of glioblastoma, characterized by both glial and sarcomatou...
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
Glioblastoma is the most aggressive form of brain tumor originating from glial cells with a maximum life expectancy of 14.6 months. Despite the establishment of multiple promising ...
A Customisable Cell Line Model of Glioblastoma
A Customisable Cell Line Model of Glioblastoma
<p><b>Glioblastoma is an extremely malignant brain tumour with one of the lowest survival rates of all cancers. Current treatments do very little to alter this prognosi...

